Clobazam monotherapy for focal or generalized seizures

Background This is an updated version of the original Cochrane Review published in Issue 10, 2014. There is a need to expand monotherapy options available to a clinician for the treatment of new focal or generalized seizures. A Cochrane systematic review for clobazam monotherapy is expected to define its place in the treatment of new‐onset or untreated seizures and highlight gaps in evidence.